media captionAldo Ceresa, who took part in the trial, says he’s “heading in the right direction” The first new treatment for Alzheimer’s disease for nearly 20 years has been approved by regulators in the United States, paving the way for its use in the UK. Aducanumab targets the underlying cause of Alzheimer’s, the most common … Continue reading US approves first new Alzheimer’s drug in 20 years